Jonsson Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.ucla.edu

Clinical Trials

Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer

Not Applicable

Terminated

Conditions: Cancer of Pancreas

Interventions: Other: Diet Only
Dietary Supplement: Nutrawell Powder
Dietary Supplement: OmegaRich fish oil supplement

First Posted Date: 2016-02-12

Last Posted Date: 2022-08-03

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 2

Registration Number: NCT02681601

Locations: 🇺🇸
UCLA Department of Medicine Center for Human Nutrition, Los Angeles, California, United States

Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma

Not Applicable

Terminated

Conditions: Pleural Epithelioid Mesothelioma
Pleural Malignant Mesothelioma

Interventions: Radiation: Hypofractionated Radiation Therapy
Radiation: Intensity-Modulated Radiation Therapy
Other: Laboratory Biomarker Analysis
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2016-02-03

Last Posted Date: 2020-07-24

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 2

Registration Number: NCT02672033

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy

Not Applicable

Withdrawn

Conditions: Stage III Prostate Adenocarcinoma

Interventions: Procedure: Biopsy of Prostate
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-11-05

Last Posted Date: 2020-07-24

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT02597894

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme

Not Applicable

Completed

Conditions: Glioblastoma
Recurrent Brain Neoplasm

Interventions: Radiation: Palliative Radiation Therapy
Other: Questionnaire Administration
Radiation: Radiation Therapy Treatment Planning and Simulation

First Posted Date: 2015-10-14

Last Posted Date: 2019-02-28

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 10

Registration Number: NCT02575027

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer

Phase 1

Withdrawn

Conditions: Recurrent Non-Small Cell Lung Carcinoma
Stage IV Non-Small Cell Lung Cancer

Interventions: Drug: Binimetinib
Drug: Docetaxel
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-05-22

Last Posted Date: 2020-07-24

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT02451865

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer

Completed

Conditions: Prostate Cancer
Elevated PSA

First Posted Date: 2015-04-23

Last Posted Date: 2020-07-24

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 300

Registration Number: NCT02425228

Locations: 🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸
University of California Los Angeles, Los Angeles, California, United States

Focal Laser Ablation of Prostate Tissue

Early Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Device: Focal Laser Ablation

First Posted Date: 2015-02-06

Last Posted Date: 2020-09-21

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 11

Registration Number: NCT02357121

Locations: 🇺🇸
University of California Los Angeles, Los Angeles, California, United States
🇺🇸
UCLA, Los Angeles, California, United States

Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases

Not Applicable

Terminated

Conditions: Iris Melanoma
Stage IIA Uveal Melanoma
Stage IIIC Uveal Melanoma
Medium/Large Size Posterior Uveal Melanoma
Stage IIB Uveal Melanoma
Stage IIIB Uveal Melanoma
Stage IIIA Uveal Melanoma

Interventions: Radiation: External Beam Radiation Therapy
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-01-13

Last Posted Date: 2020-07-24

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 2

Registration Number: NCT02336763

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy

Terminated

Conditions: Malignant Neoplasm

Interventions: Other: cytology specimen collection procedure
Other: laboratory biomarker analysis

First Posted Date: 2014-12-08

Last Posted Date: 2022-08-18

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 139

Registration Number: NCT02310594

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer

Not Applicable

Active, not recruiting

Conditions: Adenocarcinoma of the Prostate
Stage III Prostate Cancer

Interventions: Radiation: stereotactic body radiation therapy
Other: quality-of-life assessment
Other: laboratory biomarker analysis
Drug: androgen deprivation therapy

First Posted Date: 2014-11-20

Last Posted Date: 2024-01-19

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 220

Registration Number: NCT02296229

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy